# The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)

> **NCT00076076** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 822 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Roflumilast

## Key facts

- **NCT ID:** NCT00076076
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 822 (—)
- **Last updated:** 2016-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076076, "The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00076076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*